ストックスクリーナーアプリを入手
8.69
2.00%
0.17
アフターアワーズ：
8.82
0.13
+1.50%
Immix Biopharma Inc (IMMX) 最新ニュース
Immix Biopharma Inc (IMMX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Immix Biopharma Inc (IMMX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Immix Biopharma Inc (IMMX) Cash Flow - TradingKey
Immix Biopharma, Inc. Revenue Breakdown – NASDAQ:IMMX - TradingView
IMMX|Immix Biopharma Inc|Price:8.680| - TradingKey
Immix Biopharma Inc (IMMX) Income Statement - TradingKey
TradingKey - TradingKey
Immix Biopharma Inc (IMMX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Immix Biopharma Inc (IMMX) Institutional Confidence - TradingKey
Immix Biopharma Inc (IMMX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Immix Biopharma Inc (IMMX) Valuation: PE, PB & Fair Value Analysis - TradingKey
Immix Biopharma Inc (IMMX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
IMMX|Immix Biopharma Inc|Price:9.070|Chg%:+0.550 - TradingKey
Immix Biopharma Inc (IMMX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
IMMX|Immix Biopharma Inc|Price:8.593|Chg%:-0.207 - TradingKey
EQPT LAWSUIT: EquipmentShare.com Inc. Sued for Securities Law Violations; Investors Should Contact Block & Leviton To Learn How They Might Recover Their Losses - GlobeNewswire Inc.
Immix Biopharma, Inc. (IMMX) options chain - Yahoo Finance Australia
symbol__ Stock Quote Price and Forecast - CNN
IMMX Initiated Coverage by Needham -- Rating Set to Buy - GuruFocus
Needham Initiates Immix Biopharma(IMMX.US) With Buy Rating, Announces Target Price $21 - Moomoo
Fugitive doctor on run for 21 years was living as L.A. biotech exec - KTLA
Immix Biopharma drops after chief medical officer terminated - MSN
Sex offender, a fugitive for 21 years, hid in plain sight as a yacht-owning L.A. biopharma exec - Los Angeles Times
Immix Biopharma Investigated by the Portnoy Law Firm - GlobeNewswire
Five things for pharma marketers to know for Tuesday, July 21, 2026 - Medical Marketing and Media
IMMX Stock Drops Significantly on Chief Medical Officer News-Immix Biopharma Investors Encouraged to Contact Kehoe Law Firm, P.C. - ACCESS Newswire
Rhode Island fugitive appears to have gotten medical job while on the run - WJAR
Report: RI fugitive likely worked as biotech executive - WPRI.com
IMMX INVESTOR ALERT: Holzer & Holzer, LLC Announces Investigation of Immix Biopharma, Inc. - GlobeNewswire
Immix Biopharma investigated for securities fra... - Pluang
Immix Biopharma Stock Drops Significantly On News of Chief Medical Officer ArrestIMMX Investors Encouraged to Contact Kehoe Law Firm, P.C. Regarding Potential Securities Fraud Claims - TMX Newsfile
IMMX ALERT: Immix Biopharma Investigated for Securities - GlobeNewswire
Immix Biopharma exec fired following arrest after 20 years on the run - Seeking Alpha
Why is Immix Biopharma stock sliding today? By Investing.com - Investing.com Canada
Immix Biopharma stock tumbles amid fugitive CMO report By Investing.com - Investing.com Canada
Immix Biopharma stock tumbles amid fugitive CMO report - Investing.com
Immix Biopharma Terminates Richard Graydon in 2026 with No Material Business Impact - Minichart
Immix Biopharma (IMMX) reports Richard Graydon’s departure as immaterial event - Stock Titan
Immix Biopharma terminates Richard Graydon employment - Bitget
Immix Biopharma Inc. (IMMX) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
What's going on with Immix Biopharma stock Thursday? - MSN
Immix Biopharma’s Big Run Rests On Early CAR-T Data - Finimize
Enterprise value to revenue forward of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Price to book forward of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
Immix Biopharma, Inc. Financial Disclosures & SEC Filings - TradingView
Wall Street analysts think Immix Biopharma (IMMX) could surge 113.58%: Read this before placing a bet - MSN
Enterprise value to EBIT forward of Immix Biopharma, Inc. – NASDAQ:IMMX - TradingView
IMMX News | IMMIX BIOPHARMA INC (NASDAQ:IMMX) - ChartMill
Wall Street analysts see a 120.59% upside in Immix Biopharma (IMMX): Can the stock really move this high? - MSN
Immix Biopharma Q1 2026 Earnings: Narrower Net Loss but Stock DeclinesEarnings Season Review - dars.gov.et
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2000 Index - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2500 Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 2000 Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 3000E Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 3000 Growth Benchmark - marketscreener.com
Immix Biopharma, Inc.(NasdaqCM: IMMX) added to Russell 3000E Index - marketscreener.com
Immix Biopharma (IMMX) Advances 2.67% as Biotech Momentum Builds — Key Levels in FocusNHNL Divergence - dars.gov.et
Immix Biopharma, Inc. Actuals & Estimates (NASDAQ:IMMX) - TradingView
IMMX Forecast — Price Target — Prediction for 2027 - TradingView
Immix Biopharma analyst bullish but flags safety, adoption questions - MSN
All you need to know about Immix Biopharma (IMMX) rating upgrade to buy - MSN
All You Need to Know About Immix Biopharma (IMMX) Rating Upgrade to Buy - Yahoo Finance
1.97%
0.83%
大文字化:
|
ボリューム (24 時間):